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We greatly appreciated the
comments of Dr Garcia-Villareal
regarding our recent article.1 On the
basis of a previous study,2 we aimed
to analyze mitral valve hemodynamic
performance, both at rest and during
exercise, of patients with functional
mitral regurgitation (MR) who
received either restrictive annulo-
plasty or mitral valve replacement.
We agree with Dr Garcia-Villareal
that implanting the smallest ring size
(24-26 mm) would be more likely
to lead to abnormal postoperative
transmitral gradients, particularly if
the cardiac output is normal or
increased. However, in our surgical
series, only 6 patients (17%) received
a 26-mm ring, whereas 83% of our
population received a ring of 28 mm
or greater. Despite this surgical policy,1718 The Journal of Thoracic andpatients with annuloplasty showed no
exercise-induced changes in indexed
effective orifice area. In contrast, pa-
tients with mitral valve replacement
had better exercise mitral valve
hemodynamic performance andmitral
opening reserve. Thus, our results
suggest that even in patients with
relatively high implanted ring size,
exercise functional mitral stenosis,
resulting in increased systolic pulmo-
nary arterial pressure, may occur.
Our findings suggest that sparing
mitral valve replacement may be
considered as an alternative valid
surgical option, even with the obvious
limitations.
As underlined by Dr Villareal,
‘‘complete prosthetic annuloplasty
rings to treat chronic ischemic mitral
regurgitation are an absolute must as
there is an antero-posterior annular
enlargement in addition to the
asymmetric PL tethering.’’
In this context, the outcome after
mitral valve annuloplasty can largely
be predicted by a posterior high
leaflet angle (>45), regardless of the
tethering pattern.3
Any strategy aiming to avoid the
risk of persistent or recurrent MR
after surgery should be promoted and
performing a sparing mitral valve
replacement in those with high
posterior leaflet angle could be very
beneficial by reducing the need for
smaller ring size in some cases.
However, anterior leaflet restriction
should not be overlooked in under-
standing and repairing mitral valve
tethering.3
The reasonable option introduced
by Dr Villarreal, selecting rings
between 28 and 30 mm, requires
validation. Nevertheless, our data
suggest that even with a ring 28 mm
or greater, functional mitral stenosis
and limited exercise hemodynamic
performance may be frequent. This
shows the real difficulty faced by sur-
geons when selecting ring size for
mitral valve repair in patients with
functional MR; that is, to concomi-
tantly avoid persistence/recurrence ofCardiovascular Surgery c May 2014MR and risk of postoperative func-
tional mitral stenosis. Current data
from the literature seem to suggest
that whatever gains are obtained in
the reduction of recurrent MR risk by
even more restrictive annuloplasties,
they are likely to be lost by the intro-
duction of functionalmitral stenosis.1,4
Hence, despite the rule to promote
not ‘‘very aggressive undersizing,’’
restrictive mitral annuloplasty only
addresses annular dilatation with a
minimal impact on the subvalvular
tethering.
Awaiting new insights, the ideal
approach in well-selected patients
would be to consider sparing
mitral valve replacement5 or a ring
with adjunctive surgical procedures
targeting the subvalvular tethering.
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